- Home
- SMHI vs KPTI Comparison
SMHI vs KPTI Comparison
Compare SMHI & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMHI | KPTI |
|---|---|---|
| Founded | 1989 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.8M | 172.6M |
| IPO Year | 2016 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SMHI | KPTI |
|---|---|---|
| Price | $7.60 | $8.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $15.40 |
| AVG Volume (30 Days) | 164.1K | ★ 803.4K |
| Earning Date | 06-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.41 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $173,783,000.00 | $146,067,000.00 |
| Revenue This Year | $1.07 | N/A |
| Revenue Next Year | $6.86 | $46.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $3.63 | $3.51 |
| 52 Week High | $8.17 | $10.99 |
Technical Indicators
Market Signals| Indicator | SMHI | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 56.10 | 46.66 |
| Support Level | $5.87 | $5.60 |
| Resistance Level | $7.88 | $8.95 |
| Average True Range (ATR) | 0.46 | 0.70 |
| MACD | -0.06 | -0.21 |
| Stochastic Oscillator | 44.44 | 0.36 |
Price Performance
Historical ComparisonAbout SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).